LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2017/843 of 17 May 2017 approving the active substance Beauveria bassiana strain NPP111B005, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/843 of 17 May 2017 approving the active substance Beauveria bassiana strain NPP111B005, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )

Implementing Regulation (EU) 2017/843 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Approval of active substance

Article 1

Open ↗

The active substance Beauveria bassiana strain NPP111B005, as specified in Annex I, is approved subject to the conditions laid down in that Annex.

Amendments to Implementing Regulation (EU) No 540/2011

Article 2

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Beauveria bassiana strain NPP111B005 Accession number in the CNCM (Collection Nationale de Culture de Microorganismes) — Institut Pasteur, Paris, France: I-2961. Not applicable Max. level of beauvericin 24 μg/L 7 June 2017 7 June 2027 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain NPP111B005, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators and workers, taking into account that Beauveria bassiana strain NPP111B005 is to be considered, as any micro-organism, as a potential sensitizer, and paying special attention to exposure through inhalation, — the maximum level of the metabolite beauvericin in the formulated product. Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer. Conditions of use shall include risk mitigation measures, where appropriate. ( 1 )   Further details on identity and specification of active substance are provided in the review report.

ANNEX IISupplementary provisions

Open ↗

ANNEX II In Part B of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added:   Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘109 Beauveria bassiana strain NPP111B005 Accession number in the CNCM (Collection Nationale de Culture de Microorganismes) — Institut Pasteur, Paris, France: I-2961. Not applicable Max. level of beauvericin 24 μg/L 7 June 2017 7 June 2027 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain NPP111B005, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators and workers, taking into account that Beauveria bassiana strain NPP111B005 is to be considered, as any micro-organism, as a potential sensitizer, and paying special attention to exposure through inhalation, — the maximum level of the metabolite beauvericin in the formulated product. Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer. Conditions of use shall include risk mitigation measures, where appropriate.’ ( 1 )   Further details on identity and specification of active substance are provided in the review report.

Other acts of the same type
Council Regulation (EU) 2025/2605 of 12 December 2025 amending Regulation (EU) 2021/2278 suspending the Common Customs Tariff duties referred to in Article 56(2), point (c), of Regulation (EU) No 952/2013 of the European Parliament and of the Council on certain agricultural and industrial productsCouncil Regulation (EU) 2025/2614 of 12 December 2025 amending Regulation (EU) 2021/2283 opening and providing for the management of autonomous tariff quotas of the Union for certain agricultural and industrial productsCommission Delegated Regulation (EU) 2026/283 of 12 December 2025 amending the regulatory technical standards laid down in Delegated Regulation (EU) 2019/815 as regards the 2025 update of the taxonomy for the single electronic reporting formatCommission Delegated Regulation (EU) 2026/446 of 12 December 2025 supplementing Regulation (EU) 2018/1139 of the European Parliament and of the Council by laying down rules on the organisation and composition of the Board of Appeal of the European Union Aviation Safety Agency, on its members and on the rules and procedures for voting, and repealing Commission Regulation (EC) No 104/2004Commission Implementing Regulation (EU) 2025/2498 of 11 December 2025 concerning the authorisation of 4-hydroxy-2,5-dimethylfuran-3(2H)-one as a feed additive for all animal species, except cats and dogsCommission Implementing Regulation (EU) 2025/2500 of 11 December 2025 concerning the authorisation of a preparation of Bacillus velezensis NRRL B-67647, Bacillus pumilus NRRL B-67648 and Bacillus licheniformis NRRL B-67649 as a feed additive for poultry for fattening and ornamental birds (holder of authorisation: S.I.Lesaffre)Commission Implementing Regulation (EU) 2025/2501 of 11 December 2025 amending Implementing Regulation (EU) 2021/1165 as regards the use of certain products and substances in organic productionCommission Implementing Regulation (EU) 2025/2502 of 11 December 2025 concerning the authorisation of a preparation of protease produced with Bacillus subtilis CBS 148232 and viable spores of Bacillus velezensis NRRL B-50508, Bacillus velezensis NRRL B-50509 and Bacillus subtilis NRRL B-50510 as a feed additive for pigs for fattening of all Suidae species and weaned piglets of minor Suidae species (holder of authorisation: Genencor International B.V.)Commission Implementing Regulation (EU) 2025/2503 of 11 December 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced with Trichoderma citrinoviride DSM 33578 as a feed additive for poultry other than poultry for fattening, poultry reared for laying and reared for breeding and porcine species other than sows of all Suidae species (holder of authorisation: Huvepharma EOOD)Commission Implementing Regulation (EU) 2025/2505 of 11 December 2025 concerning the authorisation of guanidinoacetic acid and a preparation of guanidinoacetic acid as feed additives for weaned piglets and pigs for fattening in water for drinking and for turkeys for fattening and reared for breeding in feed and water for drinking (holder of authorisation: Alzchem Trostberg GmbH), and amending Implementing Regulation (EU) 2023/2628Commission Implementing Regulation (EU) 2025/2511 of 11 December 2025 concerning the authorisation of a preparation of Bacillus paralicheniformis DSM 33902 and Bacillus subtilis DSM 33903 as a feed additive for ruminants for milk production/reproduction (holder of authorisation: Chr. Hansen A/S)Commission Implementing Regulation (EU) 2025/2513 of 11 December 2025 concerning the authorisation of copper(II)-betaine complex as a feed additive for all animal species

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next